- Home
- TGTX vs HUMAW Comparison
TGTX vs HUMAW Comparison
Compare TGTX & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGTX
- HUMAW
- Stock Information
- Founded
- TGTX 1993
- HUMAW 2004
- Country
- TGTX United States
- HUMAW United States
- Employees
- TGTX N/A
- HUMAW 185
- Industry
- TGTX Biotechnology: Pharmaceutical Preparations
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- TGTX Health Care
- HUMAW Health Care
- Exchange
- TGTX Nasdaq
- HUMAW Nasdaq
- Market Cap
- TGTX N/A
- HUMAW N/A
- IPO Year
- TGTX 1995
- HUMAW N/A
- Fundamental
- Price
- TGTX $39.19
- HUMAW $0.37
- Analyst Decision
- TGTX Strong Buy
- HUMAW
- Analyst Count
- TGTX 6
- HUMAW 0
- Target Price
- TGTX $40.67
- HUMAW N/A
- AVG Volume (30 Days)
- TGTX 3.0M
- HUMAW 14.2K
- Earning Date
- TGTX 03-03-2025
- HUMAW 03-21-2025
- Dividend Yield
- TGTX N/A
- HUMAW N/A
- EPS Growth
- TGTX 68.03
- HUMAW N/A
- EPS
- TGTX 0.15
- HUMAW N/A
- Revenue
- TGTX $329,004,000.00
- HUMAW N/A
- Revenue This Year
- TGTX $73.72
- HUMAW N/A
- Revenue Next Year
- TGTX $38.19
- HUMAW N/A
- P/E Ratio
- TGTX $263.03
- HUMAW N/A
- Revenue Growth
- TGTX 40.80
- HUMAW N/A
- 52 Week Low
- TGTX $12.93
- HUMAW $1.18
- 52 Week High
- TGTX $43.32
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- TGTX 57.27
- HUMAW N/A
- Support Level
- TGTX $41.19
- HUMAW N/A
- Resistance Level
- TGTX $42.92
- HUMAW N/A
- Average True Range (ATR)
- TGTX 2.04
- HUMAW 0.00
- MACD
- TGTX -0.18
- HUMAW 0.00
- Stochastic Oscillator
- TGTX 46.77
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.